Overview

Clinical Trial to Evaluate the Efficacy and Safety of CKD-390 Tablet

Status:
Unknown status
Trial end date:
2018-03-01
Target enrollment:
Participant gender:
Summary
A Multicenter, Randomized, Double-blind, Parallel Design, Phase III Clinical Trial to Evaluate the Efficacy and Safety of CKD-390 tablet
Phase:
Phase 3
Details
Lead Sponsor:
Chong Kun Dang Pharmaceutical
Treatments:
Tenofovir